Eton Pharmaceuticals (ETON) Return on Equity (2018 - 2025)

Eton Pharmaceuticals has disclosed Return on Equity across 8 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Equity for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity came in at 0.0% for Q4 2025 at Eton Pharmaceuticals, up from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2023 to a low of 0.01% in Q2 2022.
• The 5-year median for Return on Equity is 0.0% (2024), against an average of 0.0%.
• Across the five-year window, Return on Equity gained 5 bps in 2021 and fell 1 bps in 2022, its largest moves.
• Eton Pharmaceuticals' Return on Equity stood at 0.0% in 2021, then sank by 533 bps to 0.01% in 2022, then jumped by 92 bps to 0.0% in 2023, then tumbled by 227 bps to 0.0% in 2024, then advanced by 1 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.